China NMPA Product Recall - Magnetic Resonance Imaging System

GE Healthcare Systems Trading Development (Shanghai) Co., Ltd. initiated a voluntary Class II recall of its Magnetic Resonance Imaging Systems. This recall, publicly reported on May 8, 2017, serves as an update to a previous recall report from June 2016 (FMI60901). The primary issue identified is a potential risk associated with these medical devices, which the company intends to resolve permanently through a software upgrade.

Operating under the oversight of the National Medical Products Administration (NMPA) in China, the company's action demonstrates compliance with medical device regulations. The voluntary recall signifies a proactive step to mitigate potential hazards to users or patients. Specific details regarding the models, specifications, and batch numbers of the affected products are documented in the "Medical Device Recall Event Report Form," an attachment referenced in the official communication.

The required action from GE Healthcare involves both the recall of the implicated systems and the deployment of a software solution to eliminate the identified risk. This process aims to ensure the safety and efficacy of the Magnetic Resonance Imaging Systems in accordance with regulatory expectations. The absence of specific inspection dates suggests this action stemmed from the company's internal identification and reporting, or a broader regulatory monitoring process.